Quick Takeaways
- This page summarizes Kenneth Bate's Form 4 filing for AVEO PHARMACEUTICALS, INC..
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 08 Jun 2022, 16:58.
Kenneth Bate - 07 Jun 2022 Form 4 Insider Report for AVEO PHARMACEUTICALS, INC.
- Role
- Director
- Signature
- /s/ Danielle V. Holland, attorney-in fact
- Issuer symbol
- N/A
- Transactions as of
- 07 Jun 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 08 Jun 2022, 16:58:57 UTC
- Previous filing
- 19 May 2022
- Next filing
- 21 Jun 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"Kenneth Bate filed Form 4 for AVEO PHARMACEUTICALS, INC. on 08 Jun 2022."
What Changed
- Previous filing in this sequence was filed on 19 May 2022.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVEO | Stock Option (right to buy) | Award | $0 | +22,500 | $0.000000 | 22,500 | 07 Jun 2022 | Common Stock | 22,500 | $4.27 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The shares underlying this option vest in twelve equal monthly installments beginning July 1, 2021, subject to the Reporting Person's continued service to the Company. |